Randomized comparative study of moxalactam and cefazolin in the treatment of acute urinary tract infections in adults.
Eighty-nine patients with clinical and laboratory evidence of acute urinary tract infection were randomized to therapy with either moxalactam (500 mg) or cefazolin (1 g) every 12 h. Escherichia coli was the predominant pathogen in both groups (92.6 versus 90.2%). Therapy was continued for 3 days aft...
Guardat en:
| Publicat a: | Antimicrob Agents Chemother |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology (ASM)
1982
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC183669/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6214996/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.22.1.32 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|